1. Home
  2. JAGX vs AGMH Comparison

JAGX vs AGMH Comparison

Compare JAGX & AGMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • AGMH
  • Stock Information
  • Founded
  • JAGX 2013
  • AGMH 2015
  • Country
  • JAGX United States
  • AGMH Hong Kong
  • Employees
  • JAGX N/A
  • AGMH N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • AGMH EDP Services
  • Sector
  • JAGX Health Care
  • AGMH Technology
  • Exchange
  • JAGX Nasdaq
  • AGMH Nasdaq
  • Market Cap
  • JAGX 3.5M
  • AGMH 3.5M
  • IPO Year
  • JAGX N/A
  • AGMH 2018
  • Fundamental
  • Price
  • JAGX $2.58
  • AGMH $2.19
  • Analyst Decision
  • JAGX Strong Buy
  • AGMH
  • Analyst Count
  • JAGX 1
  • AGMH 0
  • Target Price
  • JAGX $60.00
  • AGMH N/A
  • AVG Volume (30 Days)
  • JAGX 90.6K
  • AGMH 817.1K
  • Earning Date
  • JAGX 08-12-2025
  • AGMH 07-11-2025
  • Dividend Yield
  • JAGX N/A
  • AGMH N/A
  • EPS Growth
  • JAGX N/A
  • AGMH N/A
  • EPS
  • JAGX N/A
  • AGMH 6.43
  • Revenue
  • JAGX $11,552,000.00
  • AGMH $32,044,575.00
  • Revenue This Year
  • JAGX $22.41
  • AGMH N/A
  • Revenue Next Year
  • JAGX $30.00
  • AGMH N/A
  • P/E Ratio
  • JAGX N/A
  • AGMH $0.31
  • Revenue Growth
  • JAGX 13.93
  • AGMH N/A
  • 52 Week Low
  • JAGX $2.43
  • AGMH $1.09
  • 52 Week High
  • JAGX $110.75
  • AGMH $109.50
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 28.76
  • AGMH 38.26
  • Support Level
  • JAGX $2.61
  • AGMH $2.06
  • Resistance Level
  • JAGX $3.30
  • AGMH $2.59
  • Average True Range (ATR)
  • JAGX 0.28
  • AGMH 0.33
  • MACD
  • JAGX 0.06
  • AGMH 0.01
  • Stochastic Oscillator
  • JAGX 6.56
  • AGMH 35.06

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About AGMH AGM Group Holdings Inc.

AGM Group Holdings Inc is an investment holding company. The company focuses on blockchain-oriented ASIC chip design; high-end crypto miner production and fintech technology software service. It generates maximum revenue from the sale of cryptocurrency mining machines and standardized computing equipment.

Share on Social Networks: